Literature DB >> 21963858

Outcomes after Descemet stripping endothelial keratoplasty in glaucoma patients with previous trabeculectomy and tube shunt implantation.

Christophe Wiaux1, Elmira Baghdasaryan, Olivia L Lee, Jean-Louis Bourges, Sophie X Deng, Fei Yu, Anthony J Aldave.   

Abstract

PURPOSE: To describe the incidence of intraoperative and postoperative complications and visual outcomes in eyes with previous penetrating glaucoma surgery undergoing Descemet stripping endothelial keratoplasty (DSEK).
METHODS: A retrospective review of the first 227 cases of DSEK performed by 2 surgeons at a single institution. Data were collected regarding the performance of concurrent ocular procedures, intraoperative complications, postoperative visual outcomes, and postoperative complications, including primary graft failure, donor dislocation, endothelial rejection, and intraocular pressure (IOP) elevation.
RESULTS: Fifty-six of the 227 DSEK procedures were performed in 52 eyes with previous trabeculectomy and/or tube shunt implantation. The percentage of procedures performed in eyes with and without a history of penetrating glaucoma surgery that resulted in primary graft failure (5.4% vs. 4.1%; P = 0.71) and donor dislocation (12.5% vs. 15.2%; P = 0.83) were not statistically significantly different. Additionally, the endothelial rejection rate was not significantly different between cases performed in eyes with (1/19.2 eye-years) and without (1/20.1 eye-years) a history of glaucoma surgery (P = 0.99). The incidence of elevated IOP (≥ 25 mm Hg) after DSEK was the highest in eyes with medically controlled glaucoma (47.4%), followed by eyes without a history of glaucoma (18.3%), and was the lowest in eyes with previous glaucoma surgery (11.5%). Postoperative corrected distance visual acuity was improved over the preoperative corrected distance visual acuity in 81%, 95%, and 88% of eyes with previous glaucoma surgery, medically controlled glaucoma, and no glaucoma, respectively.
CONCLUSIONS: DSEK is an effective procedure to improve vision in the majority of eyes with advanced glaucoma after trabeculectomy and/or tube shunt implantation. The incidence of postoperative complications, such as donor dislocation, primary graft failure, and endothelial rejection, is not significantly higher in eyes with a history of glaucoma surgery before DSEK. Because almost 50% of eyes with medically controlled glaucoma before DSEK experienced IOP elevation after surgery, careful monitoring of the IOP after DSEK is especially important in this patient population.

Entities:  

Mesh:

Year:  2011        PMID: 21963858     DOI: 10.1097/ICO.0b013e3182114297

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  13 in total

1.  Outcome of Descemet stripping automated endothelial keratoplasty in eyes with an Ahmed glaucoma valve.

Authors:  Patrick J Chiam; Robert Cheeseman; Vivian W Ho; Vito Romano; Anshoo Choudhary; Mark Batterbury; Stephen B Kaye; Colin E Willoughby
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-03-17       Impact factor: 3.117

2.  Outcomes of Descemet Membrane Endothelial Keratoplasty in Patients With Previous Glaucoma Surgery.

Authors:  Carolina Aravena; Fei Yu; Sophie X Deng
Journal:  Cornea       Date:  2017-03       Impact factor: 2.651

3.  Effect of Graft Attachment Status and Intraocular Pressure on Descemet Stripping Automated Endothelial Keratoplasty Outcomes in the Cornea Preservation Time Study.

Authors:  Anthony J Aldave; Mark A Terry; Loretta B Szczotka-Flynn; Wendi Liang; Allison R Ayala; Maureen G Maguire; Robert C O'Brien; Beth Ann Benetz; John E Bokosky; Steven P Dunn; Thomas E Gillette; Kristin M Hammersmith; David R Hardten; Bennie H Jeng; Marc F Jones; Richard L Lindstrom; Kenneth J Maverick; Verinder S Nirankari; Matthew S Oliva; Irving M Raber; Christopher J Rapuano; George O D Rosenwasser; Kevin W Ross; John W Seedor; Neda Shamie; Christopher G Stoeger; Shachar Tauber; Woodford S Van Meter; David D Verdier; Jonathan H Lass
Journal:  Am J Ophthalmol       Date:  2019-03-06       Impact factor: 5.258

4.  Comparison of graft survival following penetrating keratoplasty and Descemet's stripping endothelial keratoplasty in eyes with a glaucoma drainage device.

Authors:  Shawn M Iverson; Oriel Spierer; George C Papachristou; William J Feuer; Wei Shi; David S Greenfield; Terrence P O'Brien
Journal:  Int Ophthalmol       Date:  2017-03-16       Impact factor: 2.031

5.  Management of detached graft donor by SF₆ injection following Descemet stripping automated endothelial keratoplasty of an eye with iridocorneal endothelial syndrome and Ahmed glaucoma drainage tube.

Authors:  Kansu Tahir Bozkurt; Banu Torun Acar; Suphi Acar
Journal:  Int Ophthalmol       Date:  2012-07-01       Impact factor: 2.031

6.  Considerations for Corneal Surgery With Patients in the 10th Decade of Life.

Authors:  Harry Levine; Andrea Naranjo; Jaime D Martinez; Diego S Altamirano; Steven Gayer; Terrence P O'Brien; Carol L Karp; Guillermo Amescua
Journal:  Cornea       Date:  2021-11-03       Impact factor: 3.152

Review 7.  Glaucoma management after corneal transplantation surgeries.

Authors:  Helen L Kornmann; Steven J Gedde
Journal:  Curr Opin Ophthalmol       Date:  2016-03       Impact factor: 3.761

8.  Modified Descemet's stripping automated endothelial keratoplasty for eyes with glaucoma drainage devices and shallow anterior chambers.

Authors:  Alfonso Vasquez-Perez; Syed Mohammed Naqib; Mayank A Nanavaty
Journal:  Int Ophthalmol       Date:  2017-07-03       Impact factor: 2.031

9.  Spontaneous reattachment of a posteriorly dislocated endothelial graft: a case report.

Authors:  Ka Wai Kam; Alvin L Young
Journal:  Case Rep Transplant       Date:  2013-03-03

10.  Increased Rates of Descemet's Stripping Automated Endothelial Keratoplasty (DSAEK) Graft Failure and Dislocation in Glaucomatous Eyes with Aqueous Shunts.

Authors:  Francis Char Decroos; Derek W Delmonte; Jessica H Chow; Sandra S Stinnett; Terry Kim; Alan N Carlson; Natalie A Afshari
Journal:  J Ophthalmic Vis Res       Date:  2012-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.